These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune mechanisms of uveitis: insights into disease pathogenesis and treatment. Dick AD Int Ophthalmol Clin; 2000; 40(2):1-18. PubMed ID: 10791254 [No Abstract] [Full Text] [Related]
3. [Significance of autoimmunity in various forms of uveitis]. Zierhut M; Klein R; Berg P; Thiel HJ Klin Monbl Augenheilkd; 1991 Mar; 198(3):165-73. PubMed ID: 1829128 [TBL] [Abstract][Full Text] [Related]
4. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Nussenblatt RB Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3131-41. PubMed ID: 1748544 [No Abstract] [Full Text] [Related]
7. The propensity of different strains of guinea pigs to develop experimental autoimmune uveitis. McMaster PR; Wong VG; Owens JD Mod Probl Ophthalmol; 1976; 16():62-71. PubMed ID: 1250240 [TBL] [Abstract][Full Text] [Related]
8. Round table and general discussion on aspects of autoimmune mechanisms in uveitis. Mod Probl Ophthalmol; 1976; 16():137-54. PubMed ID: 943035 [No Abstract] [Full Text] [Related]
9. Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis. Pepple KL; Lin P Ophthalmology; 2018 Dec; 125(12):1977-1983. PubMed ID: 30458922 [TBL] [Abstract][Full Text] [Related]
11. Spontaneously relapsing-remitting experimental autoimmune uveitis in rats allows successful therapeutic oral tolerance induction in ongoing disease. Huber A; Diedrichs-Möhring M; Wildner G Mol Immunol; 2015 Feb; 63(2):215-26. PubMed ID: 25085538 [TBL] [Abstract][Full Text] [Related]
12. The role of T cells in autoimmune uveitis. Becker MD; Adamus G; Davey MP; Rosenbaum JT Ocul Immunol Inflamm; 2000 Jun; 8(2):93-100. PubMed ID: 10980681 [TBL] [Abstract][Full Text] [Related]
13. Current concepts of auto-immune diseases and their therapeutic implications with particular reference to uveitis. Das Un Indian J Ophthalmol; 1993 Oct; 41(3):105-6. PubMed ID: 8125540 [No Abstract] [Full Text] [Related]
14. [Problems of autoimmunity in uveitis]. Faure JP; Offret G Doc Ophthalmol; 1966; 20():333-53. PubMed ID: 5982270 [No Abstract] [Full Text] [Related]
15. Intraocular inflammatory disease. Davis JL; Nussenblatt RB Res Publ Assoc Res Nerv Ment Dis; 1990; 68():131-9. PubMed ID: 2183308 [No Abstract] [Full Text] [Related]
16. [Use of regulatory T cells in cellular therapies in autoimmune diseases]. Boursier G; Siri A; de Boysson H Med Sci (Paris); 2012; 28(8-9):757-63. PubMed ID: 22920878 [TBL] [Abstract][Full Text] [Related]
17. What determines the site of inflammation in uveitis and chorioretinitis? Forrester JV; Liversidge J; Dick A; McMenamin P; Kuppner M; Crane I; Hossain P Eye (Lond); 1997; 11 ( Pt 2)():162-6. PubMed ID: 9349406 [No Abstract] [Full Text] [Related]
18. Immunological aspects of viral uveitis. Martenet AC Mod Probl Ophthalmol; 1976; 16():215-9. PubMed ID: 765784 [TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of experimental autoimmune uveoretinitis in HgCl2 injected rats. Saoudi A; Bellon B; de Kozak Y; Druet P Curr Eye Res; 1992; 11 Suppl():101-5. PubMed ID: 1424735 [TBL] [Abstract][Full Text] [Related]
20. Cytokines in immunotherapy of experimental uveitis. de Kozak Y; Verwaerde C Int Rev Immunol; 2002; 21(2-3):231-53. PubMed ID: 12424845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]